Literature DB >> 30242333

Association of Cadmium and Lead Exposure With the Incidence of Contrast Sensitivity Impairment Among Middle-aged Adults.

Adam J Paulsen1, Carla R Schubert1, Lauren J Johnson2, Yanjun Chen1, Dayna S Dalton1, Barbara E K Klein1, Ronald Klein1, Alex Pinto1, Karen J Cruickshanks1,2.   

Abstract

Importance: Contrast sensitivity (CS) is an important indicator of visual function that affects daily life, including mobility, visually intensive tasks, safety, and autonomy. Understanding the risk factors for CS impairment could prevent decreases in visual function. Objective: To determine the incidence of and factors associated with CS impairment in a large cohort. Design, Setting, and Participants: The Beaver Dam Offspring Study is an ongoing longitudinal cohort study of aging involving adults in Beaver Dam, Wisconsin. Participants who were free of CS impairment in both eyes at baseline were included (N = 1983). Baseline data collection occurred from June 8, 2005, through August 4, 2008, when the participants ranged from 21 to 84 years of age. Two follow-up examinations occurred at 5-year intervals: one was conducted between July 12, 2010, and March 21, 2013, and the other between July 1, 2015, and November 13, 2017. Data analysis was performed from November 27, 2017, to February 27, 2018. Main Outcomes and Measures: Contrast sensitivity testing was conducted with Pelli-Robson letter sensitivity charts, and incident impairment was defined as a log CS score less than 1.55 in either eye at any follow-up examination. Cadmium and lead levels were measured in whole blood with inductively coupled plasma mass spectrometry. Associations between baseline characteristics and CS impairment incidence were examined using Cox proportional hazard models and quantified as hazard ratios (HRs) with 95% CI.
Results: Of the 1983 participants included, 1028 (51.8%) were female and 955 (48.2%) were male, with a mean (SD) age of 48 (9.3) years. The 10-year cumulative incidence of CS impairment was 24.8% (95% CI, 22.9-26.8), similar in women (24.9%) and men (24.6%), and highest in the oldest age group (65-84 years) at 66.3%. In multivariable models, cadmium level in the highest quintile (HR, 1.35; 95% CI, 1.02-1.78), older age (HR, 1.36; 95% CI, 1.25-1.47), larger waist circumference (HR, 1.06; 95% CI, 1.01-1.11), and more plaque sites (1-3 sites: HR, 1.43; 95% CI, 1.07-1.92; 4-6 sites: HR, 2.75; 95% CI, 1.26-6.05) were among the factors associated with increased risk, while male sex (HR, 0.77; 95% CI, 0.60-0.98) and any alcohol consumption (HR, 0.61; 95% CI, 0.43-0.88) were associated with decreased risk. Results were similar when smoking status replaced cadmium exposure in the models. Lead level was not associated with increased risk. Conclusions and Relevance: This study's findings suggest that incident CS impairment was common in the 10-year follow-up, with cadmium, but not lead, exposure associated with increased risk. The associations of diminished CS with other modifiable risk factors found appear to imply that changes in behavior may reduce future incidence of CS impairment.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30242333      PMCID: PMC6292732          DOI: 10.1001/jamaophthalmol.2018.3931

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  55 in total

1.  Environmental cadmium and lead exposures and age-related macular degeneration in U.S. adults: the National Health and Nutrition Examination Survey 2005 to 2008.

Authors:  Erin W Wu; Debra A Schaumberg; Sung Kyun Park
Journal:  Environ Res       Date:  2014-06-21       Impact factor: 6.498

2.  Adult blood lead epidemiology and surveillance--United States, 2008-2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-07-01       Impact factor: 17.586

3.  Association between blood cadmium level and age-related macular degeneration in a representative Korean population.

Authors:  Eun Chul Kim; Eunyoung Cho; Donghyun Jee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

Review 4.  Nutrition and metal toxicity.

Authors:  R A Goyer
Journal:  Am J Clin Nutr       Date:  1995-03       Impact factor: 7.045

Review 5.  Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.

Authors:  Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Gregory S Hageman
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

6.  How does visual impairment affect performance on tasks of everyday life? The SEE Project. Salisbury Eye Evaluation.

Authors:  Sheila K West; Gary S Rubin; Aimee T Broman; Beatriz Muñoz; Karen Bandeen-Roche; Kathleen Turano
Journal:  Arch Ophthalmol       Date:  2002-06

7.  Excess lead in the neural retina in age-related macular degeneration.

Authors:  Jay C Erie; Jonathan A Good; John A Butz
Journal:  Am J Ophthalmol       Date:  2009-09-05       Impact factor: 5.258

8.  Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints.

Authors:  Shannon L Risacher; Darrell Wudunn; Susan M Pepin; Tamiko R MaGee; Brenna C McDonald; Laura A Flashman; Heather A Wishart; Heather S Pixley; Laura A Rabin; Nadia Paré; Jessica J Englert; Eben Schwartz; Joshua R Curtain; John D West; Darren P O'Neill; Robert B Santulli; Richard W Newman; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2012-10-18       Impact factor: 4.673

9.  Sensory Impairments and Cognitive Function in Middle-Aged Adults.

Authors:  Carla R Schubert; Karen J Cruickshanks; Mary E Fischer; Yanjun Chen; Barbara E K Klein; Ronald Klein; A Alex Pinto
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-08-01       Impact factor: 6.053

10.  Lead and cadmium levels and balance and vestibular dysfunction among adult participants in the National Health and Nutrition Examination Survey (NHANES) 1999-2004.

Authors:  Kyoung-Bok Min; Kyung-Jong Lee; Jae-Beom Park; Jin-Young Min
Journal:  Environ Health Perspect       Date:  2012-01-03       Impact factor: 9.031

View more
  6 in total

1.  Brain Aging in Midlife: The Beaver Dam Offspring Study.

Authors:  Carla R Schubert; Mary E Fischer; A Alex Pinto; Yanjun Chen; Barbara E K Klein; Ronald Klein; Michael Y Tsai; Ted S Tweed; Karen J Cruickshanks
Journal:  J Am Geriatr Soc       Date:  2019-04-01       Impact factor: 5.562

2.  Sensorineural Impairments, Cardiovascular Risk Factors, and 10-Year Incidence of Cognitive Impairment and Decline in Midlife: The Beaver Dam Offspring Study.

Authors:  Carla R Schubert; Karen J Cruickshanks; Mary E Fischer; A Alex Pinto; Yanjun Chen; Guan-Hua Huang; Barbara E K Klein; Ronald Klein; James S Pankow; Adam J Paulsen; Dayna S Dalton; Ted S Tweed
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-10-04       Impact factor: 6.053

3.  Macular Ganglion Cell-Inner Plexiform Layer as a Marker of Cognitive and Sensory Function in Midlife.

Authors:  Natascha Merten; Adam J Paulsen; A Alex Pinto; Yanjun Chen; Lauren K Dillard; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Carla R Schubert; Karen J Cruickshanks
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-09-16       Impact factor: 6.053

4.  Inflammation, metabolic dysregulation and environmental neurotoxins and risk of cognitive decline and impairment in midlife.

Authors:  Carla R Schubert; Mary E Fischer; A Alex Pinto; Adam J Paulsen; Yanjun Chen; Guan-Hua Huang; Barbara E K Klein; Michael Y Tsai; Natascha Merten; Karen J Cruickshanks
Journal:  Neurol Sci       Date:  2022-09-17       Impact factor: 3.830

5.  Factors Associated with the Macular Ganglion Cell-Inner Plexiform Layer Thickness in a Cohort of Middle-aged U.S. Adults.

Authors:  Adam J Paulsen; Alex Pinto; Natascha Merten; Yanjun Chen; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Carla R Schubert; Karen J Cruickshanks
Journal:  Optom Vis Sci       Date:  2021-03-01       Impact factor: 2.106

6.  Generational Differences in the 10-year Incidence of Impaired Contrast Sensitivity.

Authors:  Adam J Paulsen; Alex Pinto; Mary E Fischer; Yanjun Chen; Guan-Hua Huang; Barbara E K Klein; Ronald Klein; Karen J Cruickshanks
Journal:  Ophthalmic Epidemiol       Date:  2020-07-21       Impact factor: 1.648

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.